Legal Updates

Home / Legal Updates
Product and process claims in chemistry patent applications
October 19, 2021
Reform of Regulation of Gene-Edited Organisms – An update
October 18, 2021
Claiming priority from a CIP design
October 14, 2021
The Eurasian Industrial Design: a new regional IP protection came into force in the Designs landscape from 1st June 2021
October 11, 2021
Full Spectrum IP cover for Software
October 5, 2021
Description Amendments
September 23, 2021
G1/19 – Pedestrian Crowd Simulation
September 20, 2021
Clarity or Confusion?
September 16, 2021
Patenting Blockchain
September 13, 2021
Compulsory licences in times of crisis
September 10, 2021
Amended Rule 19(1) – ‘Designation of the inventor’ at the EPO
September 9, 2021
EPO Patent Applications – Trends and Highlights from 2020
September 7, 2021
An Innovative Ireland
August 30, 2021
Brexit – approaching deadline of 30 September 2021 for filing UK Trade Mark comparable applications
August 23, 2021
Design registration in the European Union- an unusual case
August 20, 2021
UK – Brexit reminder of approaching deadline of 30 September for filing GB comparables
August 16, 2021
Multiple Design Applications in Japan
August 12, 2021
Designs on your Brand
August 5, 2021
A Busy Year for the UKIPO
August 3, 2021
Trade Mark Replacement – What is Replacement and what are your options post-Brexit?
July 20, 2021
Decision in case G 1/21
July 16, 2021
Unitary Patent Court Update
July 15, 2021
Designs – Comparisons between deferred publication in UK/EUIPO
July 13, 2021
No decision in case G1/21
July 8, 2021
China joins the dots on designs
July 5, 2021
Some like it hot
July 1, 2021
Changes to Patent Law in Japan
July 1, 2021
Double patenting updates in Europe
June 25, 2021
Members of the European Parliament Vote for Waiver of IP Rights to Vaccines During Pandemic
June 21, 2021
EPO Enlarged Board of Appeal to consider double-patenting
June 1, 2021
G1/21 proceedings adjourned! What happened?
May 28, 2021
EU to consult on new regulatory framework for new genomic techniques
May 28, 2021
From PDF to DOCX at the USPTO
May 25, 2021
Further Developments in Videoconference Proceedings at the EPO
May 24, 2021
IP Waiver and the COVID-19 Vaccines
May 18, 2021
Case Study: Admissibility of late-filed facts and evidence during Opposition Proceedings
May 13, 2021